nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroxyaluminium—VDAC2—connective tissue—atherosclerosis	0.062	0.108	CbGeAlD
Dihydroxyaluminium—VDAC2—cardiovascular system—atherosclerosis	0.0539	0.0936	CbGeAlD
Dihydroxyaluminium—VDAC1—connective tissue—atherosclerosis	0.0491	0.0852	CbGeAlD
Dihydroxyaluminium—VDAC2—adipose tissue—atherosclerosis	0.0475	0.0826	CbGeAlD
Dihydroxyaluminium—VDAC3—cardiovascular system—atherosclerosis	0.0449	0.078	CbGeAlD
Dihydroxyaluminium—VDAC1—cardiovascular system—atherosclerosis	0.0427	0.0742	CbGeAlD
Dihydroxyaluminium—TNNC1—connective tissue—atherosclerosis	0.0421	0.0731	CbGeAlD
Dihydroxyaluminium—VDAC3—adipose tissue—atherosclerosis	0.0396	0.0688	CbGeAlD
Dihydroxyaluminium—VDAC1—adipose tissue—atherosclerosis	0.0377	0.0654	CbGeAlD
Dihydroxyaluminium—TNNC1—cardiovascular system—atherosclerosis	0.0366	0.0636	CbGeAlD
Dihydroxyaluminium—VDAC2—liver—atherosclerosis	0.0333	0.0579	CbGeAlD
Dihydroxyaluminium—TNNC1—adipose tissue—atherosclerosis	0.0323	0.0561	CbGeAlD
Dihydroxyaluminium—VDAC3—liver—atherosclerosis	0.0278	0.0482	CbGeAlD
Dihydroxyaluminium—VDAC1—liver—atherosclerosis	0.0264	0.0459	CbGeAlD
Dihydroxyaluminium—Lung disorder—Niacin—atherosclerosis	0.0199	0.047	CcSEcCtD
Dihydroxyaluminium—Polyuria—Niacin—atherosclerosis	0.0117	0.0275	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Rosuvastatin—atherosclerosis	0.00975	0.023	CcSEcCtD
Dihydroxyaluminium—Urinary retention—Niacin—atherosclerosis	0.00973	0.023	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Niacin—atherosclerosis	0.00862	0.0203	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Pravastatin—atherosclerosis	0.00849	0.02	CcSEcCtD
Dihydroxyaluminium—Chills—Lovastatin—atherosclerosis	0.0074	0.0174	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Niacin—atherosclerosis	0.0071	0.0167	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Pravastatin—atherosclerosis	0.00699	0.0165	CcSEcCtD
Dihydroxyaluminium—Back pain—Lovastatin—atherosclerosis	0.00694	0.0164	CcSEcCtD
Dihydroxyaluminium—Chills—Simvastatin—atherosclerosis	0.00692	0.0163	CcSEcCtD
Dihydroxyaluminium—Infection—Rosuvastatin—atherosclerosis	0.00687	0.0162	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Niacin—atherosclerosis	0.00682	0.0161	CcSEcCtD
Dihydroxyaluminium—Back pain—Ezetimibe—atherosclerosis	0.00681	0.0161	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Lovastatin—atherosclerosis	0.00676	0.016	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Pravastatin—atherosclerosis	0.00672	0.0158	CcSEcCtD
Dihydroxyaluminium—Vertigo—Lovastatin—atherosclerosis	0.00645	0.0152	CcSEcCtD
Dihydroxyaluminium—Chills—Niacin—atherosclerosis	0.00635	0.015	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Simvastatin—atherosclerosis	0.00633	0.0149	CcSEcCtD
Dihydroxyaluminium—Chills—Pravastatin—atherosclerosis	0.00626	0.0148	CcSEcCtD
Dihydroxyaluminium—Vertigo—Simvastatin—atherosclerosis	0.00603	0.0142	CcSEcCtD
Dihydroxyaluminium—Pain—Rosuvastatin—atherosclerosis	0.00591	0.0139	CcSEcCtD
Dihydroxyaluminium—Infection—Lovastatin—atherosclerosis	0.00582	0.0137	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Niacin—atherosclerosis	0.00581	0.0137	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Pravastatin—atherosclerosis	0.00572	0.0135	CcSEcCtD
Dihydroxyaluminium—Infection—Ezetimibe—atherosclerosis	0.00571	0.0135	CcSEcCtD
Dihydroxyaluminium—Vertigo—Niacin—atherosclerosis	0.00554	0.0131	CcSEcCtD
Dihydroxyaluminium—Urticaria—Rosuvastatin—atherosclerosis	0.00549	0.013	CcSEcCtD
Dihydroxyaluminium—Oedema—Simvastatin—atherosclerosis	0.00548	0.0129	CcSEcCtD
Dihydroxyaluminium—Vertigo—Pravastatin—atherosclerosis	0.00545	0.0129	CcSEcCtD
Dihydroxyaluminium—Infection—Simvastatin—atherosclerosis	0.00544	0.0128	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00509	0.012	CcSEcCtD
Dihydroxyaluminium—Oedema—Niacin—atherosclerosis	0.00503	0.0119	CcSEcCtD
Dihydroxyaluminium—Pain—Lovastatin—atherosclerosis	0.00501	0.0118	CcSEcCtD
Dihydroxyaluminium—Oedema—Pravastatin—atherosclerosis	0.00495	0.0117	CcSEcCtD
Dihydroxyaluminium—Infection—Pravastatin—atherosclerosis	0.00492	0.0116	CcSEcCtD
Dihydroxyaluminium—Pain—Ezetimibe—atherosclerosis	0.00491	0.0116	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Niacin—atherosclerosis	0.00491	0.0116	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Rosuvastatin—atherosclerosis	0.00473	0.0112	CcSEcCtD
Dihydroxyaluminium—Hypotension—Niacin—atherosclerosis	0.0047	0.0111	CcSEcCtD
Dihydroxyaluminium—Pain—Simvastatin—atherosclerosis	0.00469	0.0111	CcSEcCtD
Dihydroxyaluminium—Urticaria—Lovastatin—atherosclerosis	0.00465	0.011	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Lovastatin—atherosclerosis	0.00463	0.0109	CcSEcCtD
Dihydroxyaluminium—Dizziness—Rosuvastatin—atherosclerosis	0.00457	0.0108	CcSEcCtD
Dihydroxyaluminium—Urticaria—Ezetimibe—atherosclerosis	0.00456	0.0108	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Ezetimibe—atherosclerosis	0.00454	0.0107	CcSEcCtD
Dihydroxyaluminium—Urticaria—Simvastatin—atherosclerosis	0.00435	0.0103	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Simvastatin—atherosclerosis	0.00433	0.0102	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Lovastatin—atherosclerosis	0.00432	0.0102	CcSEcCtD
Dihydroxyaluminium—Pain—Niacin—atherosclerosis	0.0043	0.0101	CcSEcCtD
Dihydroxyaluminium—Pain—Pravastatin—atherosclerosis	0.00424	0.00999	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Ezetimibe—atherosclerosis	0.00423	0.00998	CcSEcCtD
Dihydroxyaluminium—Nausea—Rosuvastatin—atherosclerosis	0.00411	0.00968	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Simvastatin—atherosclerosis	0.00404	0.00952	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Lovastatin—atherosclerosis	0.00401	0.00945	CcSEcCtD
Dihydroxyaluminium—Urticaria—Niacin—atherosclerosis	0.004	0.00943	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Niacin—atherosclerosis	0.00398	0.00938	CcSEcCtD
Dihydroxyaluminium—Urticaria—Pravastatin—atherosclerosis	0.00394	0.00928	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Ezetimibe—atherosclerosis	0.00393	0.00927	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Pravastatin—atherosclerosis	0.00392	0.00924	CcSEcCtD
Dihydroxyaluminium—Dizziness—Lovastatin—atherosclerosis	0.00387	0.00914	CcSEcCtD
Dihydroxyaluminium—Dizziness—Ezetimibe—atherosclerosis	0.0038	0.00896	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Simvastatin—atherosclerosis	0.00375	0.00884	CcSEcCtD
Dihydroxyaluminium—Vomiting—Lovastatin—atherosclerosis	0.00372	0.00878	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Niacin—atherosclerosis	0.00371	0.00874	CcSEcCtD
Dihydroxyaluminium—Vomiting—Ezetimibe—atherosclerosis	0.00365	0.00862	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Pravastatin—atherosclerosis	0.00365	0.00861	CcSEcCtD
Dihydroxyaluminium—Dizziness—Simvastatin—atherosclerosis	0.00362	0.00855	CcSEcCtD
Dihydroxyaluminium—Vomiting—Simvastatin—atherosclerosis	0.00348	0.00822	CcSEcCtD
Dihydroxyaluminium—Nausea—Lovastatin—atherosclerosis	0.00348	0.00821	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Niacin—atherosclerosis	0.00344	0.00812	CcSEcCtD
Dihydroxyaluminium—Nausea—Ezetimibe—atherosclerosis	0.00341	0.00805	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Pravastatin—atherosclerosis	0.00339	0.00799	CcSEcCtD
Dihydroxyaluminium—Dizziness—Niacin—atherosclerosis	0.00333	0.00785	CcSEcCtD
Dihydroxyaluminium—Dizziness—Pravastatin—atherosclerosis	0.00328	0.00773	CcSEcCtD
Dihydroxyaluminium—Nausea—Simvastatin—atherosclerosis	0.00325	0.00768	CcSEcCtD
Dihydroxyaluminium—Vomiting—Niacin—atherosclerosis	0.0032	0.00754	CcSEcCtD
Dihydroxyaluminium—Vomiting—Pravastatin—atherosclerosis	0.00315	0.00743	CcSEcCtD
Dihydroxyaluminium—Nausea—Niacin—atherosclerosis	0.00299	0.00705	CcSEcCtD
Dihydroxyaluminium—Nausea—Pravastatin—atherosclerosis	0.00294	0.00694	CcSEcCtD
